In a surprising move, India's central bank cut its benchmark interest rate to 5.5%, the lowest since August 2022. This decision, driven by softening inflation and lower growth, raises questions about future monetary policy as the economy adapts to global challenges.
Father's Day is just around the corner, and there's still time to snag the Samsung Galaxy S25 Ultra at an incredible discount of $300. This top-tier smartphone offers exceptional camera performance and new AI features, making it the perfect gift for dad. Don't miss out!
Get ready for the spectacular Strawberry Moon this June! Discover why it’s the lowest full moon of the year and the best time to catch a glimpse of this celestial wonder.
Tensions flared as Denzel Washington confronted a photographer at Cannes for his film 'Highest 2 Lowest.' Despite the clash, the night turned triumphant with an Honorary Palme d’Or and a standing ovation for the film.
Spike Lee took a jab at Donald Trump during the Cannes press conference for his film 'Highest 2 Lowest,' discussing social media's role in American morals and the impact of proposed film tariffs.
Spike Lee makes a triumphant return to Cannes with 'Highest 2 Lowest', a Denzel Washington-led crime thriller inspired by Akira Kurosawa's classic. The film received a six-minute ovation and Washington was honored with a surprise Palme d’Or!
Consumer sentiment in the U.S. has hit a new low as inflation expectations soar, raising fears of a potential economic downturn. With prices on the rise and uncertainty surrounding trade policies, Americans are growing increasingly worried about their financial futures.
A recent survey reveals U.S. consumers are increasingly anxious about tariffs causing inflation, with sentiment dipping to one of its lowest levels. Will a recent tariff pause ease their concerns?
April's inflation rate declined unexpectedly to 2.3%, sparking discussions on the impact of President Trump's tariffs and potential interest rate cuts. What does this mean for consumers?
In a surprising announcement, Trump declares he will sign an executive order to slash prescription drug prices in the U.S. to match those of other high-income countries, potentially reducing costs by 30% to 80%.